Announcements Trials
Browse Landscape

Status

Recruiting 1551Active not recruiting 857Completed 809Not yet recruiting 480Terminated 164Enrolling by invitation 56Withdrawn 40Suspended 22Available 5No longer available 1Approved for marketing 1

Sponsor Class

INDUSTRY 4OTHER 1

Study Type

Expanded_access 5

Sponsor

Cancer Type

Lymphoid 13Sarcoma 10Other hematologic neoplasm 10Thoracic 9Genitourinary 9CNS 9Gastrointestinal 8Tumor-Agnostic 6Myeloid 6Gynecologic 5Breast 5Plasma cell 4Head & Neck 4Dermatologic 3Endocrine 2Other solid neoplasm 1NET 1Classical hematology 1

Conditions

Breast Neoplasms 4Sarcoma 2Prostatic Neoplasms 2Pancreatic Neoplasms 2Ovarian Neoplasms 2Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Osteosarcoma 1Neurofibrosarcoma 1Neoplasms 1Lymphoma, Non-Hodgkin 1Hodgkin Disease 1Glioblastoma 1Chordoma 1Chondrosarcoma 1Carcinoma, Squamous Cell 1Carcinoma, Non-Small-Cell Lung 1Brain Neoplasms 1

Interventions

ribociclib 1leronlimab 1Proton Pump Inhibitors 1Hydrocortisone 1Alpelisib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Available × Breast × 1 year × Clear all
NCT07536815 2026-04-27

An Open-Label, Multicenter, Non-Randomized Expanded Access Protocol (EAP) Designed to Provide Leronlimab to Patients With Locally Advanced or Metastatic Triple-Negative Breast Cancer (mTNBC)

CytoDyn, Inc.

Available
Breast

Triple Negative Breast Neoplasms

NCT04085653 2026-04-14

Managed Access Programs for BYL719, Alpelisib

Novartis

Available
Breast

Breast Neoplasms

NCT05038631 2026-04-13

Managed Access Programs for LEE011, Ribociclib

Novartis

Available
Breast

Breast Neoplasms

NCT04091295 2026-03-04

BLESSED: Expanded Access for DNG64-CAR-V for Advanced Pancreatic Cancer, Sarcoma and Carcinoma of Breast

Aveni Foundation

Available
BreastGastrointestinalGenitourinaryGynecologicSarcomaThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Chondrosarcoma, Chordoma, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma, Osteosarcoma, Neurofibrosarcoma

NCT05974410 2025-10-02

Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer Patients

AVM Biotechnology Inc

Available
BreastCNSGastrointestinalGenitourinaryGynecologicLymphoidSarcoma

Brain Neoplasms, Breast Neoplasms, Carcinoma, Squamous Cell, Glioblastoma, Hodgkin Disease, Lymphoma, Non-Hodgkin, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡